Beauty Health price target raised to $2.00 from $1.30 at Jefferies

Investing.com - Jefferies raised its price target on The Beauty Health Company (NASDAQ:SKIN) to $2.00 from $1.30 while maintaining a Hold rating on the stock. The company, currently trading at $1.98 with a market cap of $249 million, maintains impressive gross profit margins of 61.5%, according to InvestingPro data.

The firm cited Beauty Health’s second-quarter sales and EBITDA results, which exceeded estimates, as well as the company’s full-year sales and EBITDA guidance that was raised above Street expectations. While revenue declined 15.3% in the last twelve months, InvestingPro analysis suggests net income growth is expected this year.

Jefferies noted that Beauty Health expects resilient consumables demand across Americas and EMEA regions, though average selling price and tariff pressures will likely persist through year-end.

The research firm highlighted that tariff exposure should decline with the completed transition to a distributor model in China, a positive development for the company’s cost structure.

Jefferies expressed encouragement regarding Beauty Health’s growing focus on innovation, specifically pointing to upcoming skincare launches planned for the fourth quarter and increased R&D investment in both consumables and devices.

In other recent news, Beauty Health Co reported its second-quarter earnings for 2025, demonstrating a performance that exceeded market expectations. The company announced an earnings per share (EPS) of $0.03, which was well above the forecasted EPS of -$0.06. Revenue also outpaced projections, totaling $78.2 million compared to the anticipated $74.51 million. These results highlight a strong financial quarter for Beauty Health Co. While the earnings report has drawn attention, there are no recent updates regarding mergers or acquisitions involving the company. Analysts from various firms have not issued recent upgrades or downgrades for Beauty Health Co. Investors will be watching closely for any further announcements or developments.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.